BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8180578)

  • 1. Modulation of tumour associated antigen expressed on human squamous cell carcinoma cell lines by recombinant interferon-alpha.
    Maniar HS; Desai SA; Chiplunkar SV; Amin MK; Rao RS; Gangal SG
    Eur J Cancer B Oral Oncol; 1993 Jan; 29B(1):57-61. PubMed ID: 8180578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody against human squamous-cell-carcinoma-associated antigen.
    Tatake RJ; Amin KM; Maniar HS; Jambhekar NA; Srikhande SS; Gangal SG
    Int J Cancer; 1989 Nov; 44(5):840-5. PubMed ID: 2583866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of surface antigen expression on human breast carcinoma cells by recombinant human interferons.
    Tran R; Hand PH; Greiner JW; Pestka S; Schlom J
    J Interferon Res; 1988 Feb; 8(1):75-88. PubMed ID: 3130426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parameters involved in the enhancement of monoclonal antibody targeting in vivo with recombinant interferon.
    Guadagni F; Schlom J; Pothen S; Pestka S; Greiner JW
    Cancer Immunol Immunother; 1988; 26(3):222-30. PubMed ID: 3383205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulatory effect of cytokines on natural killer and antibody dependent cellular cytotoxicity directed to squamous cell carcinoma targets by lymphocytes from oral cancer patients.
    Desai SA; Maniar HS; Rao RS; Fakih AR; Gangal SG
    Eur J Cancer B Oral Oncol; 1993 Jan; 29B(1):69-73. PubMed ID: 8180580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of tumor-associated antigens on human oral squamous cell carcinomas using monoclonal antibody 3F8E3.
    Pichan D; Thomas ML; Damodaran A; Fakih AR; Chiplunkar SV
    Tumori; 2000; 86(1):64-9. PubMed ID: 10778769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.
    Gastl G; Marth C; Leiter E; Gattringer C; Mayer I; Daxenbichler G; Flener R; Huber C
    Cancer Res; 1985 Jul; 45(7):2957-61. PubMed ID: 3924395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody (G10) to a common antigen of human squamous cell carcinoma: binding of the antibody to the H type 2 blood group determinant.
    Kimmel KA; Carey TE; Judd WJ; McClatchey KD
    J Natl Cancer Inst; 1986 Jan; 76(1):9-19. PubMed ID: 2416979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential responsiveness of cloned mammary carcinoma cell populations to the human recombinant leukocyte interferon enhancement of tumor antigen expression.
    Greiner JW; Tobi M; Fisher PB; Langer JA; Pestka S
    Int J Cancer; 1985 Aug; 36(2):159-66. PubMed ID: 3160671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon gamma enhances lymphokine-activated killer cell adhesion but not lysis of head and neck squamous cell carcinoma.
    Scher RL; Carras A; Schwab D; Richtsmeier WJ; Koch WM
    Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1271-5. PubMed ID: 7576474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of a monoclonal antibody (K 931) to a squamous cell carcinoma associated antigen identified as the 17-1A antigen.
    Quak JJ; Van Dongen G; Brakkee JG; Hayashida DJ; Balm AJ; Snow GB; Meijer CJ
    Hybridoma; 1990 Aug; 9(4):377-87. PubMed ID: 2210778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck.
    Schrijvers AH; Quak JJ; Uyterlinde AM; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
    Cancer Res; 1993 Sep; 53(18):4383-90. PubMed ID: 8364934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA restriction and T-cell-receptor V beta gene expression of cytotoxic T lymphocytes reactive with human squamous-cell carcinoma of the head and neck.
    Yasumura S; Weidmann E; Hirabayashi H; Johnson JT; Herberman RB; Whiteside TL
    Int J Cancer; 1994 May; 57(3):297-305. PubMed ID: 8168988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preparation and application of monoclonal antibodies to recombinant human IFN alpha].
    Wu M; Ai Y; Ren R; Liang Y; Li J; Song W; Yang D; Sun J; Cheng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):261-3. PubMed ID: 12665935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of the intercellular adhesion molecule (ICAM-1) on squamous cell carcinoma by interferon gamma.
    Scher RL; Koch WM; Richtsmeier WJ
    Arch Otolaryngol Head Neck Surg; 1993 Apr; 119(4):432-8. PubMed ID: 8096142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 11p deletions and breakpoints in squamous cell carcinoma: association with altered reactivity with the UM-E7 antibody.
    Bradford CR; Kimmel KA; Van Dyke DL; Worsham MJ; Tilley BJ; Burk D; del Rosario F; Lutz S; Tooley R; Hayashida DJ
    Genes Chromosomes Cancer; 1991 Jul; 3(4):272-82. PubMed ID: 1958593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-proliferative activity of interferon-alpha on human squamous carcinoma of tongue cell lines.
    King WW; Lam PK; Li AK
    Cancer Lett; 1994 Sep; 85(1):55-8. PubMed ID: 7923102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation by interferon alpha and gamma of the expression of a melanoma-associated antigen detected by autologous antibody.
    Vlock DR; Toporowicz A; Arnold B
    Melanoma Res; 1992 Jul; 2(2):105-14. PubMed ID: 1643429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of tumor-associated antigen expression on human pancreatic and prostate carcinoma cells in vitro by alpha- and gamma-interferons.
    Sivinski CL; Lindner DJ; Borden EC; Tempero MA
    J Immunother Emphasis Tumor Immunol; 1995 Oct; 18(3):156-65. PubMed ID: 8770771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of tumor antigen expression by recombinant human interferons: enhanced targeting of monoclonal antibodies to carcinomas.
    Greiner JW; Guadagni F; Hand PH; Pestka S; Noguchi P; Fisher PB; Schlom J
    Cancer Treat Res; 1990; 51():413-32. PubMed ID: 1977458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.